Selected research
Industry Growth & Trends
Global Dengvaxia Industry Growth and Trends Forecast to 2032
Market perspective
The global Dengvaxia market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Dengvaxia is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Dengvaxia is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Dengvaxia is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Dengvaxia include Sanofi. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Dengvaxia market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Dengvaxia market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Dengvaxia market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Dengvaxia.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Dengvaxia market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Dengvaxia Market by Company
Sanofi
Dengvaxia Segment by Type
Dengvaxia
Other
Dengvaxia Segment by Application
Public Sector
Private Sector
Dengvaxia Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengvaxia market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dengvaxia and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengvaxia.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dengvaxia manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Dengvaxia in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dengvaxia
- Other
Applications
- Public Sector
- Private Sector
Companies covered
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Dengvaxia Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Dengvaxia Sales Estimates and Forecasts (2021-2032)
- 1.3 Dengvaxia Market by Type
- 1.3.1 Dengvaxia
- 1.3.2 Other
- 1.4 Global Dengvaxia Market Size by Type
- 1.4.1 Global Dengvaxia Market Size Overview by Type (2021-2032)
- 1.4.2 Global Dengvaxia Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Dengvaxia Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Dengvaxia Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Dengvaxia Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Dengvaxia Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Dengvaxia Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Dengvaxia Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Dengvaxia Industry Trends
- 2.2 Dengvaxia Industry Drivers
- 2.3 Dengvaxia Industry Opportunities and Challenges
- 2.4 Dengvaxia Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Dengvaxia Revenue (2021-2026)
- 3.2 Global Top Players by Dengvaxia Sales (2021-2026)
- 3.3 Global Top Players by Dengvaxia Price (2021-2026)
- 3.4 Global Dengvaxia Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Dengvaxia Major Company Production Sites & Headquarters
- 3.6 Global Dengvaxia Company, Product Type & Application
- 3.7 Global Dengvaxia Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Dengvaxia Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Dengvaxia Players Market Share by Revenue in 2025
- 3.8.3 2025 Dengvaxia Tier 1, Tier 2, and Tier 3
4 Dengvaxia Regional Status and Outlook
- 4.1 Global Dengvaxia Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Dengvaxia Historic Market Size by Region
- 4.2.1 Global Dengvaxia Sales in Volume by Region (2021-2026)
- 4.2.2 Global Dengvaxia Sales in Value by Region (2021-2026)
- 4.2.3 Global Dengvaxia Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Dengvaxia Forecasted Market Size by Region
- 4.3.1 Global Dengvaxia Sales in Volume by Region (2027-2032)
- 4.3.2 Global Dengvaxia Sales in Value by Region (2027-2032)
- 4.3.3 Global Dengvaxia Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Dengvaxia by Application
- 5.1 Dengvaxia Market by Application
- 5.1.1 Public Sector
- 5.1.2 Private Sector
- 5.2 Global Dengvaxia Market Size by Application
- 5.2.1 Global Dengvaxia Market Size Overview by Application (2021-2032)
- 5.2.2 Global Dengvaxia Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Dengvaxia Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Dengvaxia Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Dengvaxia Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Dengvaxia Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Dengvaxia Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Dengvaxia Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Sanofi
- 6.1.1 Sanofi Company Information
- 6.1.2 Sanofi Business Overview
- 6.1.3 Sanofi Dengvaxia Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Sanofi Dengvaxia Product Portfolio
- 6.1.5 Sanofi Recent Developments
7 North America by Country
- 7.1 North America Dengvaxia Sales by Country
- 7.1.1 North America Dengvaxia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Dengvaxia Sales by Country (2021-2026)
- 7.1.3 North America Dengvaxia Sales Forecast by Country (2027-2032)
- 7.2 North America Dengvaxia Market Size by Country
- 7.2.1 North America Dengvaxia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Dengvaxia Market Size by Country (2021-2026)
- 7.2.3 North America Dengvaxia Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Dengvaxia Sales by Country
- 8.1.1 Europe Dengvaxia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Dengvaxia Sales by Country (2021-2026)
- 8.1.3 Europe Dengvaxia Sales Forecast by Country (2027-2032)
- 8.2 Europe Dengvaxia Market Size by Country
- 8.2.1 Europe Dengvaxia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Dengvaxia Market Size by Country (2021-2026)
- 8.2.3 Europe Dengvaxia Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Dengvaxia Sales by Country
- 9.1.1 Asia-Pacific Dengvaxia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Dengvaxia Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Dengvaxia Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Dengvaxia Market Size by Country
- 9.2.1 Asia-Pacific Dengvaxia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Dengvaxia Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Dengvaxia Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Dengvaxia Sales by Country
- 10.1.1 South America Dengvaxia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Dengvaxia Sales by Country (2021-2026)
- 10.1.3 South America Dengvaxia Sales Forecast by Country (2027-2032)
- 10.2 South America Dengvaxia Market Size by Country
- 10.2.1 South America Dengvaxia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Dengvaxia Market Size by Country (2021-2026)
- 10.2.3 South America Dengvaxia Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Dengvaxia Sales by Country
- 11.1.1 Middle East and Africa Dengvaxia Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Dengvaxia Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Dengvaxia Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Dengvaxia Market Size by Country
- 11.2.1 Middle East and Africa Dengvaxia Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Dengvaxia Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Dengvaxia Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Dengvaxia Value Chain Analysis
- 12.1.1 Dengvaxia Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Dengvaxia Production Mode & Process
- 12.2 Dengvaxia Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Dengvaxia Distributors
- 12.2.3 Dengvaxia Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst